Ligand validation:6P9R

U20: uridine-5'-diphosphate-3-O-(R-3-hydroxymyristoyl)-N-acetyl-D-glucosamine

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6P9R_U20_A_301	93%	43%	0.071	0.964	0.89	1.32	2	7	0	0	100%	1
6P9Q_U20_A_301	93%	42%	0.072	0.966	0.94	1.31	3	6	0	0	100%	0.96
2QIA_U20_A_901	27%	26%	0.174	0.822	1.4	1.58	5	13	0	0	100%	1
4WY2_U20_A_401	38%	43%	0.173	0.876	0.96	1.22	2	6	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.